Table 5.
Summary of change in EORTC QLC 30 scores following treatment with SMK therapy, by item
| Parameter | Screening | End of Cycle 1 |
|---|---|---|
| Global Health Status | ||
| Global health status | 61.2 ± 25.0 | 80.7 ± 14.1 |
| Functional Scales | ||
| Physical functioning | 77.1 ± 21.5 | 87.6 ± 14.2 |
| Role functioning | 74.1 ± 29.1 | 85.6 ± 23.8 |
| Emotional functioning | 76.1 ± 23.0 | 85.9 ± 17.1 |
| Cognitive functioning | 76.4 ± 25.4 | 85.1 ± 22.4 |
| Social functioning | 72.4 ± 32.5 | 83.3 ± 24.0 |
| Symptom Scales | ||
| Fatigue | 39.1 ± 26.8 | 26.8 ± 24.4 |
| Nausea and vomiting | 10.9 ± 21.9 | 5.75 ± 12.8 |
| Pain | 35.1 ± 31.3 | 17.2 ± 22.9 |
| Dyspnea | 18.4 ± 24.5 | 10.3 ± 10.3 |
| Insomnia | 25.3 ± 32.9 | 11.5 ± 20.5 |
| Appetite loss | 19.5 ± 30.2 | 10.3 ± 22.0 |
| Constipation | 12.6 ± 24.3 | 9.20 ± 21.6 |
| Diarrhea | 10.3 ± 18.0 | 9.20 ± 17.6 |
| Financial difficulties | 31.0 ± 36.7 | 25.3 ± 30.4 |
N = 29; Mean and SD are provided